Related Experiment Video
Updated: Jul 2, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
A novel functional screen in human cells identifies MOCA as a negative regulator of Wnt signaling
Elanite Caspi1, Rina Rosin-Arbesfeld
1Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Abstract:
Aberrant Wnt signal transduction is involved in many human diseases such as cancer and neurodegenerative disorders. The key effector protein of the canonical Wnt pathway is beta-catenin, which functions with T-cell factor/lymphoid enhancer factor (TCF/LEF) to activate gene transcription that leads to expression of Wnt target genes. In this study we provide results obtained from a novel functional screen of a human brain cDNA library used to identify 63 genes that are putative negative Wnt regulators. These genes were divided into eight functional groups that include known canonical and noncanonical Wnt pathway components and genes that had not yet been assigned to the Wnt pathway. One of the groups, the presenilin-binding proteins, contains the modifier of cell adhesion (MOCA) gene. We show that MOCA is a novel inhibitor of Wnt/beta-catenin signaling. MOCA forms a complex with beta-catenin and inhibits transcription of known Wnt target genes. Epistasis experiments indicate that MOCA acts to reduce the levels of nuclear beta-catenin, increase the levels of membrane-bound beta-catenin, and enhances cell-cell adhesion. Therefore, our data indicate that MOCA is a novel Wnt negative regulator and demonstrate that this screening approach can be a rapid means for isolation of new Wnt regulators.
Insights
Aberrant Wnt signaling contributes to diseases like cancer. Researchers identified MOCA as a novel Wnt pathway inhibitor, which complexes with beta-catenin to suppress Wnt target genes and enhance cell adhesion.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Aberrant Wnt signal transduction is implicated in various human diseases, including cancer and neurodegenerative disorders.
- Beta-catenin is the key effector protein in the canonical Wnt pathway, partnering with T-cell factor/lymphoid enhancer factor (TCF/LEF) to drive Wnt target gene expression.
Purpose of the Study:
- To identify novel negative regulators of the Wnt pathway using a functional screen of a human brain cDNA library.
- To characterize the role of the modifier of cell adhesion (MOCA) gene, identified through the screen, as a Wnt pathway inhibitor.
Main Methods:
- A novel functional screen of a human brain cDNA library was employed to identify genes regulating Wnt signaling.
- The interaction of MOCA with beta-catenin and its effect on Wnt target gene transcription were investigated.
- Epistasis experiments were conducted to elucidate the mechanism of MOCA action within the Wnt pathway.
Main Results:
- The screen identified 63 putative negative Wnt regulators, categorized into eight functional groups.
- MOCA was identified as a novel inhibitor of Wnt/beta-catenin signaling.
- MOCA forms a complex with beta-catenin, inhibiting Wnt target gene transcription, reducing nuclear beta-catenin, increasing membrane-bound beta-catenin, and enhancing cell-cell adhesion.
Conclusions:
- MOCA is a novel negative regulator of Wnt signaling.
- The screening approach provides a rapid method for isolating new Wnt pathway regulators.
- Understanding MOCA's role may offer new therapeutic strategies for Wnt-related diseases.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
